跨导管时代的功能性腹:诊断和治疗途径
Francesca Maria Di Muro1,2, Luigi Spadafora3, Angela Buonpane4
1Cardiology Unit, Cardiovascular and Thoracic Department, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Largo Città di Ippocrate, 84131 Salerno, Italy.
Journal of personalized medicine
|August 27, 2025
概括
功能性腹 (FMR) 的管理正在发展. 精准医学,整合先进的成像和患者选择,指导过导管干预,以改善复杂病例的结果.
科学领域:
- 心脏病学
- 医学成像
- 干预心脏病学
背景情况:
- 功能性腹 (FMR) 显著影响预后,通常源于心肌病.
- 准则导向的医学治疗 (GDMT) 有助,但经常需要额外的干预措施.
- 心房动 (AF) 和心室失调需要特殊的治疗策略.
研究的目的:
- 审查精准药物方法来选择患有FMR的患者进行透导管治疗.
- 强调将临床数据与多式成像进行整合,以实现准确的表型和规划.
- 详细介绍目前的跨导管策略和新兴技术,以实现个性化的FMR管理.
主要方法:
- 对当前文献和临床指导方针的审查.
- 重点是多模式成像 (心声,心脏MRI,CT) 用于患者的评估.
- 基于患者特异性解剖学和病理生理学的穿导管装置选择的讨论.
主要成果:
- 在40-45%的患者中,GDMT改善了MR的严重程度,但许多患者仍然需要进一步的干预.
- 通过皮肤干预适用于持续的中度至重度MR,其症状未解决,符合特定标准.
- 多模式成像对于复杂的病例至关重要,确保准确的表型和程序规划.
结论:
- 精准医学方法优化了通过导管治疗的患者选择.
- 量身定制的设备选择和程序规划是成功干预的关键.
- 新兴技术有望进一步个性化FMR管理.
相关概念视频
Mitral Regurgitation III: Medical Management
28
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
28
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
50
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
50
Mitral Valve Prolapse II: Assessment and Management
39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
Mitral Stenosis II: Clinical features and Diagnostic Tests
37
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
37
Mitral Regurgitation IV: Nursing Management
80
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
80


